HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
STA BX909
structure in first source
Also Known As:
STA-BX-909; STA-BX909
Networked:
1
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Coordination Complexes: 576
Metalloporphyrins: 178
STA BX909: 1
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Azoles: 2138
Pyrroles: 369
Tetrapyrroles: 70
Porphyrins: 3316
Metalloporphyrins: 178
STA BX909: 1
Fused-Ring Heterocyclic Compounds
4 or More Rings Heterocyclic Compounds
Tetrapyrroles: 70
Porphyrins: 3316
Metalloporphyrins: 178
STA BX909: 1
Polycyclic Compounds: 6
Macrocyclic Compounds: 15
Tetrapyrroles: 70
Porphyrins: 3316
Metalloporphyrins: 178
STA BX909: 1
Biological Factors: 2472
Biological Pigments: 1
Porphyrins: 3316
Metalloporphyrins: 178
STA BX909: 1
Related Diseases
1.
Glioma (Gliomas)
07/01/1999 - "
A boron concentration study in cultured glioma cell lines (U-251, U-87, 9L) demonstrated an increased boron concentration as a function of exposure time to STA-BX909, while the boron concentration remained stable with increasing exposure time to BSH.
"
2.
Neoplasms (Cancer)
07/01/1999 - "
In the 9L rat brain tumor model, STA-BX909 achieved a higher boron tumor/blood ratio 24 h after injection in comparison to BSH.
"
3.
Brain Neoplasms (Brain Tumor)
07/01/1999 - "
In the 9L rat brain tumor model, STA-BX909 achieved a higher boron tumor/blood ratio 24 h after injection in comparison to BSH.
"
Related Drugs and Biologics
1.
Boron